NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + Wall Street braces fo...
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
* Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of Thais * This approval builds on Abbott's biosimilar portfolio in Asia Pacific, following recent launches inMalaysia and Indi...
Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge
- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid Test Device comes with an easy-to-use nasal swab to detect active coronavirus infections in as earl...
Abbott's Fast, Reliable and Convenient COVID-19 Tests Ramp Up Indonesia's Testing Capability
- Southeast Asia's most populous nation1 expands use of fastest available molecular point-of-care technology and an antigen rapid test device that needs just a nasal swab, to detect active coronavirus infections at massive scale - Delivering reliable results in minutes, Abbott's COVID-19 testing ...
Abbott Teams Up with Football Star Cristiano Ronaldo to Inspire Young People to Donate Blood
ABBOTT PARK, Ill., Oct. 22, 2015 /PRNewswire/ -- Blood is an essential component for life, but many people do not think about it until the need is critical. Each year 234 million major operations are performed worldwide, many involving blood transfusions or treatments resulting in a continuou...
Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
ABBOTT PARK, Ill., July 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business andAbbott's developed markets ph...
Abbott and Fonterra to Form Strategic Alliance for Dairy Farming in China
ABBOTT PARK, Ill. and AUCKLAND, New Zealand, July 11, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) and Fonterra Co-operative Group Ltd today announced the signing of an agreement to develop a proposed dairy farm hub inChina. The strategic alliance, which is subject to Chinese regulatory approval, will...
Abbott Builds Long-Term Commitment in China
ABBOTT PARK, Ill., July 11, 2014 /PRNewswire/ -- Today's announcement of a proposed strategic alliance with Fonterra to develop dairy farms is the latest in a series of investments Abbott (NYSE: ABT) has made inChina, deepening its commitment in the country. In June, Abbott opened a state-of-the-...
Abbott Completes Separation of Research-Based Pharmaceuticals Business
- Major Milestone Marks 125th Anniversary of Company's Founding - Continues Diverse Healthcare Leadership in Diagnostics, Medical Devices, Nutrition and Branded Generic Pharmaceuticals - Set to Deliver Industry-Leading Growth, Expanding Margins and Strong Cash Flow - Businesses Aligned With...
